003 INTRAVASCULARES.pdf - Secretaría Distrital de Salud

Guías intrahospitalarias: Dispositivos intravasculares | 51111. Mendelson MH, Short LJ, Schechter CB, et al. Study of a needlelessintermittent intravenous-access system for peripheral infusions:analysis of staff, patient, and institutional outcomes. InfectionControl & Hospital Epidemiology 1998; 19:401-6.112. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. Aprospective clinical study to investigate the microbial contaminationofa needleless connector. J Hosp Infect 2000; 45:165-8.113. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associatedwith needleless device use and the importance of infection-controlpractices in the home health care setting. Journal of InfectiousDiseases 1999; 179:442-8.114. Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Tzanetou KG,Mostrou GI. Enterobacter sepsis in infants and children due tocontaminated intravenous fluids. Infection Control 1984; 5:471-7.115. Maki D, Mermel L. Infections due to infusion therapy. In: BennettJV, Brachman PS, eds. Hospital Infections. Philadelphia:Lippincott-Raven, 1998:689-724.116. Macias AE, Munoz JM, Bruckner DA, et al. Parenteral infusionsbacterial contamination in a multi-institutional survey inMexico: considerations for nosocomial mortality. Am J InfectControl 1999; 27:285-90.117. Munoz JM, Macias AE, Guerrero FJ, Hernandez I, Medina H, VargasE. [Control of pediatric nosocomial bacteremia by a programbased on culturing of parenteral solutions in use]. Salud PublicaMex 1999; 41:S32-7.118. Rosenthal VD GS. Evaluación Del Efecto En La Tasa Y En Los CostosDe Las Bateriemias Asociadas A Catéter Vascular Al IncorporarUn Frasco Flexible Con Sistema Cerrado De Solución Parenteral.Informe Preliminar, X Congreso Chileno De Infecciones IntrahospitalariasY Epidemiologia Hospitalaria, Concepcion, Chile, 2001.119. Crnich CJ, Maki DG. The role of intravascular devices in sepsis.Current Infectious Disease Reports 2001; 3:497-506.120. Clinical sepsis and death in a newborn nursery associated withcontaminated parenteral medications--Brazil, 1996. MMWR MorbMortal Wkly Rep 1998; 47:610-2.121. Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, SteffeeWP. Microbial growth comparisons of five commercial parenterallipid emulsions. Jpen: Journal of Parenteral & Enteral Nutrition1984; 8:391-5.